Australia markets closed

Advanced Proteome Therapeutics Corporation (APC-H.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.00500.0000 (0.00%)
At close: 04:55PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 205.63k
Enterprise value 194.91k
Trailing P/E 2.79
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.60
Enterprise value/revenue N/A
Enterprise value/EBITDA -8.69

Trading information

Stock price history

Beta (5Y monthly) 1.50
52-week change 3-50.00%
S&P500 52-week change 326.94%
52-week high 30.0300
52-week low 30.0050
50-day moving average 30.0100
200-day moving average 30.0106

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 541.13M
Implied shares outstanding 641.13M
Float 836.95M
% held by insiders 110.16%
% held by institutions 10.00%
Shares short (15 May 2024) 41.79k
Short ratio (15 May 2024) 4N/A
Short % of float (15 May 2024) 4N/A
Short % of shares outstanding (15 May 2024) 40.00%
Shares short (prior month 15 Apr 2024) 41.79k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 308 May 2019
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 308 May 2019

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 July 2022
Most-recent quarter (mrq)30 Apr 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-126.04%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -921.8k
Net income avi to common (ttm)-2.04M
Diluted EPS (ttm)-0.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)38.7k
Total cash per share (mrq)0
Total debt (mrq)30.79k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.73
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-934.86k
Levered free cash flow (ttm)-1.41M